Aandelen in “Productie van biologische producten”
| Aandeel | Datum | Koers | Evolutie |
|---|---|---|---|
Cardiff Oncology Inc |
4/02 | 4,270 USD
+6,48% |
+6,48% |
|
CASI Pharmaceuticals Inc |
4/02 | 2,550 USD
+8,05% |
+8,05% |
|
Cel-Sci Corp. |
4/02 | 0,384 USD
+0,92% |
+0,92% |
|
Celldex Therapeutics Inc. |
4/02 | 23,150 USD
-2,11% |
-2,11% |
|
Cellectis |
4/02 | 1,630 USD
+4,49% |
+4,49% |
Cellectis |
4/02 | 1,508 EUR
+0,53% |
+0,53% |
|
Champions Oncology Inc |
4/02 | 10,740 USD
+7,29% |
+7,29% |
|
Cidara Therapeutics Inc |
4/02 | 20,040 USD
+5,75% |
+5,75% |
|
Coherus Biosciences Inc |
4/02 | 1,160 USD
+4,50% |
+4,50% |
|
CRISPR Therapeutics AG |
4/02 | 40,490 USD
+1,23% |
+1,23% |
|
Curis Inc |
4/02 | 3,470 USD
-0,57% |
-0,57% |